Abstract

Intratumor Heterogeneity (ITH) is a functionally important property of tumor tissue and may be involved in drug resistance mechanisms. Although descriptions of ITH can be traced back to very early reports about cancer tissue, mechanistic investigations are still limited by the precision of analysis methods and access to relevant tissue sources. PDX models have provided a reproducible source of tissue with at least a partial representation of naturally occurring ITH. We investigated the properties of phenotypically distinct cell populations by Fluorescence activated cell sorting (FACS) tissue derived cells from multiple tumors from a triple negative breast cancer patient derived xenograft (PDX) model. We subsequently subjected each population to in depth gene expression analysis. Our findings suggest that process related gene expression changes (caused by tissue dissociation and FACS sorting) are restricted to Immediate Early Genes (IEGs). This allowed us to discover highly reproducible gene expression profiles of distinct cellular compartments identifiable by cell surface markers in this particular tumor model. Within the context of data from a previously published model our work suggests that gene expression profiles associated with hypoxia, stemness and drug resistance may reside in tumor subpopulations predictably growing in PDX models. This approach provides a novel opportunity for prospective mechanistic studies of ITH.

Highlights

  • Phenotypic differences between patients with the same tumor type and among cancer cells within the same patient have always been integral to descriptions of tumor appearance [1], yet they were neglected as a source of useful information for a long time

  • Influence of tissue dissociation and Fluorescence activated cell sorting (FACS) sorting on gene expression profiles Our study was based on pairwise comparisons of gene expression profiles for (8) different cell populations from a triple negative breast cancer patient derived xenograft (PDX) model

  • We set out to determine if sample handling or flow cytometry introduced bias in transcriptional profiling and show different subpopulation profiles indicating complex Intratumor Heterogeneity (ITH) in tumor tissue from a breast cancer PDX model

Read more

Summary

Introduction

Phenotypic differences between patients with the same tumor type (intertumor heterogeneity) and among cancer cells within the same patient (intratumor heterogeneity/ITH) have always been integral to descriptions of tumor appearance [1], yet they were neglected as a source of useful information for a long time. While intertumor heterogeneity has been integrated into clinical practice, in breast cancer [2], ITH remains to be included as a standard part of cancer tissue analysis. The past 10–15 years have seen a “re-discovery” of ITH as a mainstream topic.

Objectives
Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.